NEW YORK, Jan. 23, 2012 /PRNewswire/ -- NeoStem,
Inc.[1] (NYSE Amex:
NBS) ("NeoStem" or the "Company"), an international
biopharmaceutical company with a focus on cell-based
therapeutic development, today announced that its
Chief Medical Officer, the lead investigator for its PreSERVE Phase
2 clinical trial[2] for AMR-001
for preservation of heart function in post acute myocardial
infarction patients, and the President of its subsidiary,
Progenitor Cell
Therapy, LLC[3], have been
invited to present at the Seventh International Conference on
Cell
Therapy for Cardiovascular Disease held from
January 25-27, 2012 in New York City. The event is being
organized by the Cardiovascular Research Foundation and
will be held at the Myrna L. Daniels Auditorium in the Vivien
and Seymour Milstein Family Heart Center at NYPH/Columbia
University Medical Center.
According to the conference, the program will be dedicated to
the evolving field of cell-based therapies being developed for
the repair and regeneration of cardiac and vascular disease, as
well as related diseases such as diabetes and stroke. This
year's conference will focus on preclinical and clinical
studies on the path to commercialization, highlighting the
status of molecular, cell, and tissue products in addition to
delivery systems. Leaders from the international community will
convene to present their work, experiences, observations, and
opinions on the benefits and unmet challenges of cell-based
therapies.
- At 4:30 PM on Wednesday, January 25, Andrew L. Pecora, MD,
FACP, Chief Medical Officer of NeoStem, will speak on an
industry session entitled "Focus on Acute Injury Technologies." - At 9:20 AM on Thursday, January 26, Arshed A. Quyyumi, MD,
FRCP, FACC, principal investigator of the PreSERVE AMI Phase
2 trial[4] and
Professor of Medicine and Cardiology at Emory University,
will speak on a panel entitled "Early and Next Phase Studies"
within a session entitled "Acute Injury: STEMI and NSTEMI". - From 7:30 to 8:30 AM on Friday, January 27, Robert A.
Preti, PhD, President of Progenitor Cell
Therapy[5] will
speak as part of Industry Session III entitled "Focus on
Procedure, Systems Management, and Advanced Technologies."
Dr. Pecora said, "As a presenter at the first industry
session, I look forward to informing industry leaders about the
PreSERVE Phase 2 clinical trial for AMI which is now open for
enrollment and may provide data readout 18 months from the
first patient enrollment, as well as discussing the recent
patent issued to use the Amorcyte technology beyond
cardiovascular disease."
Dr. Robin L. Smith, Chairman and CEO of NeoStem, said, "This
conference represents validation that the development of
cell therapies for diseases outside of bone marrow
transplantation is progressing as represented by their current
clinical data. Our acquisition of Amorcyte last year has
positioned NeoStem to be a leader in the cell therapy
cardiovascular space. We are excited to be a part of the
developing science represented by this important conference and
share our expertise represented by the progress with Amorcyte
and our capabilities to assist the field with the manufacturing
services of PCT."
About the Cardiovascular Research Foundation
According to the Cardiovascular Research Foundation, their role
in interventional cardiovascular medicine is unique: conducting
research on therapies, pharmacology, and devices during the
earliest stages of development, confirming safety and efficacy
in human clinical trials, and educating the medical community
regarding appropriate use of these new procedures and
technologies. By providing research, evaluation, and education
under one roof, CRF has a unique ability to generate important
research questions, test and refine groundbreaking new
therapies, and ensure that these treatments are available to
patients at the earliest opportunity. For more information,
please visit http://www.celltherapy.crf.org[6].
About NeoStem, Inc. and Amorcyte, LLC, a NeoStem company
NeoStem, Inc. ("NeoStem") is a leader in the development and
manufacture of cell therapies. NeoStem has a strategic
combination of revenues, including that which is derived from
the contract manufacturing services performed by Progenitor
Cell Therapy, LLC, a NeoStem company. That manufacturing base
is one of the few cGMP facilities available for contracting in
the burgeoning cell therapy industry, and it is the combination
of PCT's core expertise in manufacturing and NeoStem's
extensive research capabilities that positions the company as a
leader in cell therapy development. Amorcyte, LLC, also a
NeoStem company, is developing a cell therapy for the treatment
of cardiovascular disease. Amorcyte's lead compound, AMR-001,
represents NeoStem's most clinically advanced therapeutic and
is open for enrollment in a Phase 2 trial for the preservation
of heart function after a heart attack. Amorcyte expects
to begin a Phase 1 clinical trial in 2012 for AMR-001 for the
treatment of patients with congestive heart failure. Athelos
Corporation, also a NeoStem company, is developing a T-cell
therapy for a range of autoimmune conditions with our partner
Becton-Dickinson. NeoStem's pre-clinical assets include
its VSEL™ Technology platform for regenerative medicine, which
NeoStem believes to be an endogenous, pluripotent,
non-embryonic stem cell that has the potential to change the
paradigm of cell therapy as we know it today.
For more information on NeoStem and Amorcyte, please visit
http://www.neostem.com[7] and
http://www.amorcyte.com[8].
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements reflect management's current
expectations, as of the date of this press release, and involve
certain risks and uncertainties. Forward looking statements
include statements herein with respect to the successful
execution of the Company's business and medical strategy,
including with respect to the successful development of AMR-001
and other cell therapies, about which no assurance can be
given. The Company's actual results could differ materially
from those anticipated in these forward- looking statements as
a result of various factors. Factors that could cause future
results to materially differ from the recent results or those
projected in forward-looking statements include the "Risk
Factors" described in the Company's definitive proxy statement
filed with the Securities and Exchange Commission on September
16, 2011 and in the Company's periodic filings with the
Securities and Exchange Commission. The Company's further
development is highly dependent on future medical and research
developments and market acceptance, which is outside its
control.
For more information, please |
|
|
|
Trout Group |
NeoStem, Inc. |
Gitanjali Jain Ogawa, Vice |
Robin Smith, CEO |
Phone: +1-646-378-2949 |
Phone: +1-212-584-4174 |
Email: gogawa@troutgroup.com[9] |
Email: rsmith@neostem.com[10] |
References
-
^ NeoStem, Inc.
(us.lrd.yahoo.com) -
^ PreSERVE Phase 2 clinical
trial (us.lrd.yahoo.com) -
^ Progenitor Cell Therapy, LLC
(us.lrd.yahoo.com) -
^ PreSERVE AMI Phase 2 trial
(us.lrd.yahoo.com) -
^ Progenitor Cell Therapy
(us.lrd.yahoo.com) -
^ http://www.celltherapy.crf.org
(us.lrd.yahoo.com) -
^ http://www.neostem.com
(us.lrd.yahoo.com) -
^ http://www.amorcyte.com
(us.lrd.yahoo.com) -
^ gogawa@troutgroup.com
(finance.yahoo.com) -
^ rsmith@neostem.com
(finance.yahoo.com)
Read more from the original source:
Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy ...
- More Stem Cells Extracted For Later Use For My MS - March 14th, 2011 [March 14th, 2011]
- Stem Cell Institute Panama City Panama - April 1st, 2011 [April 1st, 2011]
- Cells That Heal Us From Cradle To Grave: A Quantum Leap in Medical Science - April 8th, 2011 [April 8th, 2011]
- Macular Degeneration Improved With Stem Cells - April 8th, 2011 [April 8th, 2011]
- Stem Cell Therapy for Kidney Failure - April 15th, 2011 [April 15th, 2011]
- SIRA: Could Stem Cell Therapy Renew Your Body Cells? - April 22nd, 2011 [April 22nd, 2011]
- Stem Cell Therapy for Autism - May 20th, 2011 [May 20th, 2011]
- Stem Cell Therapy for Critical Limb Ischemia - May 21st, 2011 [May 21st, 2011]
- STEM CELLS FOR MACULAR DEGENERATION Sam Smith's story.wmv - May 21st, 2011 [May 21st, 2011]
- Stem Cell Therapy Success - May 21st, 2011 [May 21st, 2011]
- Doctors Use Stem Cells to Grow New Windpipes - May 21st, 2011 [May 21st, 2011]
- Dog Undergoes Stem Cell Therapy - May 23rd, 2011 [May 23rd, 2011]
- Stem Cell Therapy for Multiple Sclerosis - May 23rd, 2011 [May 23rd, 2011]
- Dogs now getting stem cell therapy - May 24th, 2011 [May 24th, 2011]
- Stem Cell Therapy for Rheumatoid Arthritis - May 30th, 2011 [May 30th, 2011]
- Stem Cell Therapy for Type II Diabetes - May 31st, 2011 [May 31st, 2011]
- Stem Cell Therapy for Cerebral Palsy - May 31st, 2011 [May 31st, 2011]
- Visions Episode 92: Stem Cells Discovery - May 31st, 2011 [May 31st, 2011]
- Stem Cell Therapy For Alzheimer's/Dementia - June 1st, 2011 [June 1st, 2011]
- Stem Cell Patient Richard H. MS Treatment - June 10th, 2011 [June 10th, 2011]
- Stem Cell Therapy Injections - June 12th, 2011 [June 12th, 2011]
- Stem Cells Used to Grow Windpipes - June 20th, 2011 [June 20th, 2011]
- Stem Cell Therapy for Stroke - Gary Steinberg, Stanford University - June 21st, 2011 [June 21st, 2011]
- Lou Gehrig's Disease (ALS): UCSD Team's Stem Cell Therapy Approach - June 23rd, 2011 [June 23rd, 2011]
- Stem Cell Therapy Cream: Less Wrinkles In 30 Days or Less Anti-Wrinkle Cream That Works - June 26th, 2011 [June 26th, 2011]
- Stem Cell Therapy for Spinal Cord Injury - Injured Airline Pilot Flies Again - June 27th, 2011 [June 27th, 2011]
- Clinical Advances in Adult Stem Cell Therapy: Dr. Jorge Paz - June 27th, 2011 [June 27th, 2011]
- Stem Cell Injection Treatment - Stem Cell Therapy - June 27th, 2011 [June 27th, 2011]
- Stem Cell Therapy MS: Sam Harrell and The Superbowl - June 27th, 2011 [June 27th, 2011]
- Documentary: Stem Cell Therapy for Muscular Dystrophy - Ryan Benton's Story - June 30th, 2011 [June 30th, 2011]
- Stem Cell Therapy--Hillcrest Animal Hospital - July 14th, 2011 [July 14th, 2011]
- WAVE3 News Adipose Stem Cell Therapy - July 20th, 2011 [July 20th, 2011]
- Lou Gehrig's Disease (ALS): Stem Cell Therapy - A Patient's Perspective - July 23rd, 2011 [July 23rd, 2011]
- University of Melbourne announce Stem Cells Discovery - July 28th, 2011 [July 28th, 2011]
- Stem Cell Therapy (Regenerative Medicine) in New Jersey - August 9th, 2011 [August 9th, 2011]
- Spinal Cord Injury - Stem Cell Therapy - August 9th, 2011 [August 9th, 2011]
- Dr. Craig Saunders Adult Stem Cell Therapy - August 9th, 2011 [August 9th, 2011]
- Embryonic stem cell therapy in China (www.esctherapy.com) - August 13th, 2011 [August 13th, 2011]
- Mesenchymal stem cells and marrow stromal cells - August 15th, 2011 [August 15th, 2011]
- Mesenchymal Stem Cells in Regenerative Medicine: Of Hopes and Challenges - August 15th, 2011 [August 15th, 2011]
- Cardiomyogenic differentiation of Mesenchymal Stem cells (KUM2/9-15c) - August 15th, 2011 [August 15th, 2011]
- SENS4 - Engineered Mesenchymal Stem Cells - The Road to Skeletal Tissue Regeneration (1/3) - August 15th, 2011 [August 15th, 2011]
- Mesenchymal stem cells and marrow stromal cells---2nd--- - August 15th, 2011 [August 15th, 2011]
- Cadiomyogenesis of human mesenchymal stem cells - August 15th, 2011 [August 15th, 2011]
- Mesenchymal Stem Cells Transplantation In Heart.wmv - August 15th, 2011 [August 15th, 2011]
- Ying Liu discusses IPS cell therapy for ALS - August 15th, 2011 [August 15th, 2011]
- Non-controversial Stem Cells: Rationale for Clinical Use: Neil Riordan, Ph.D. - Miami, FL - August 16th, 2011 [August 16th, 2011]
- From Surgical Repair to Stem Cell Repair: A Surgeon's Journey by Leonard Smith MD, FACS - August 16th, 2011 [August 16th, 2011]
- Bone Marrow Aspiration - Stem Cell Therapy - August 16th, 2011 [August 16th, 2011]
- Non-controversial Stem Cells: Rationale for Clinical Use - Dr. Neil Riordan - August 16th, 2011 [August 16th, 2011]
- TEDxSingapore - Susan Lim - Hype and hope of stem cell research - August 16th, 2011 [August 16th, 2011]
- Cryo-Lip Instruction Video.VOB.flv - August 16th, 2011 [August 16th, 2011]
- Stem Cells Repair Damaged Heart [7-07-2011] - August 16th, 2011 [August 16th, 2011]
- Andalusian Stem Cell Bank - August 16th, 2011 [August 16th, 2011]
- Adult Stem Cell Therapy Clinical Advances - Dr. Jorge Paz in San Diego, CA March 2011 - August 16th, 2011 [August 16th, 2011]
- Mesenchymal Stem Cells Drive New MS Study/Treatment - August 26th, 2011 [August 26th, 2011]
- Sims 2 Mafia Story Part 7 - Farewell, Godfather/Stem Cell Medicine - August 28th, 2011 [August 28th, 2011]
- STEM CELLS - Mesenchymal Stem Cells (Balzitt).flv - August 30th, 2011 [August 30th, 2011]
- Regenerative Medicine With Stem Cell Therapy Injections at an Arizona pain clinic (602) 507-6550 - September 3rd, 2011 [September 3rd, 2011]
- Stem Cell Research: Huntington's Disease - September 5th, 2011 [September 5th, 2011]
- Autism Stem Cell Trip - September 6th, 2011 [September 6th, 2011]
- Before/After Stem Cell for COPD: From Unable to Walk, to Dancing at My Daughter's Wedding - September 6th, 2011 [September 6th, 2011]
- Regenerative Medicine with Placenta Extracts and Stem Cell Therapies - Dr. Janethy Balakrishnan - September 6th, 2011 [September 6th, 2011]
- Stem Cells - September 6th, 2011 [September 6th, 2011]
- The Politics and Promise of Stem Cell Research - September 6th, 2011 [September 6th, 2011]
- Stem cell therapy in Guatemala - (closer than China) - September 7th, 2011 [September 7th, 2011]
- Stem Cell Therapy for Cerebral Palsy - Holly Catalano - September 9th, 2011 [September 9th, 2011]
- Clinical Advances in Adult Stem Cell Therapy - Dr. Jorge Paz Rodriguez (Miami) - September 9th, 2011 [September 9th, 2011]
- CryoLip Stem Cell Preservation - September 20th, 2011 [September 20th, 2011]
- Dr. Gonzalez tells his story of Stem Cell Treatment and Stem Cell Therapy - September 23rd, 2011 [September 23rd, 2011]
- A Three Minute Cell Passage - September 23rd, 2011 [September 23rd, 2011]
- Bone Marrow - Stem Cell Prolotherapy - September 23rd, 2011 [September 23rd, 2011]
- Stem Cell Therapy- Interview with Indian Surgeon - September 23rd, 2011 [September 23rd, 2011]
- Cryo-Lip.f4v - September 23rd, 2011 [September 23rd, 2011]
- CryoCord Corporate Video (2 Mins) - September 23rd, 2011 [September 23rd, 2011]
- SENS4 - Engineered Mesenchymal Stem Cells - The Road to Skeletal Tissue Regeneration (3/3) - September 23rd, 2011 [September 23rd, 2011]
- What are stem cells? - September 24th, 2011 [September 24th, 2011]
- Dental stem cell bank in Hyderabad - September 24th, 2011 [September 24th, 2011]
- Stem Cell Therapeutics: Tissue Regeneration - Christopher J. Centeno, MD - September 25th, 2011 [September 25th, 2011]
- Stem Cell Types and Sources - September 25th, 2011 [September 25th, 2011]